MedPath
Found 1 clinical trials|View Analysis
Sort by:

A Phase II Trial of Cabozantinib with Patients with Refractory GCTs

Phase 2
Recruiting
Conditions
Seminoma
Ovarian Germ Cell Tumor
Germ Cell Tumor
Non-seminomatous Germ Cell Tumor
Interventions
First Posted Date
2021-05-06
Last Posted Date
2025-01-09
Lead Sponsor
Jennifer King
Target Recruit Count
50
Registration Number
NCT04876456
Locations
🇺🇸

Indiana University Melvin & Bren Simon Cancer Center, Indianapolis, Indiana, United States

© Copyright 2025. All Rights Reserved by MedPath